Skip to main content

Advertisement

Log in

Interstitial Lung Disease in Rheumatoid Arthritis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is the most common systemic autoimmune disease in the United States, affecting 1% to 2% of the adult population. Although joints and synovium are the primary targets in this disorder, extra-articular manifestations involving the lungs can lead to significant morbidity and excess mortality. Among the various pulmonary complications that occur in RA, interstitial lung disease (ILD) is the most damaging, with effects ranging from subclinical inflammation/scarring to end-stage pulmonary fibrosis. New insights during the past several years have underscored the epidemiologic impact of clinically/functionally significant RA-associated ILD (RA-ILD) and have begun to identify factors contributing to the pathogenesis of this potentially devastating complication of RA. Despite these advancements, the complexity of RA-ILD and the lack of reliable predictors for disease progression highlight the need for improved biomarker development. Establishing such detailed molecular signatures will ultimately guide the application and timing of therapeutic agents that include immunomodulators as well as newly studied antifibrotic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Nannini C, Ryu JH, Matteson EL: Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 2008, 20:340–346.

    Article  PubMed  Google Scholar 

  2. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC: Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003, 48:917–926.

    Article  PubMed  Google Scholar 

  3. Brown KK: Rheumatoid lung disease. Proc Am Thorac Soc 2007, 4:443–448.

    Article  PubMed  Google Scholar 

  4. •• Gochuico BR, Avila NA, Chow CK, et al.: Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008, 168:159–166. Through the use of multiplex ELISA-based technology, this study examined the relationship between levels of various cytokines/chemokines in bronchoalveolar lavage fluid and subtype of RA-ILD, demonstrating that specific cytokine profiles predict radiographic progression in “subclinical” RA-ILD.

    Article  CAS  PubMed  Google Scholar 

  5. Metafratzi ZM, Georgiadis AN, Ioannidou CV, et al.: Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007, 36:338–344.

    Article  CAS  PubMed  Google Scholar 

  6. Young A, Koduri G, Batley M, et al.: Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2007, 46:350–357.

    Article  CAS  Google Scholar 

  7. Ayhan-Ardic FF, Oken O, Yorgancioglu ZR, et al.: Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 2006, 25:213–218.

    Article  PubMed  Google Scholar 

  8. Cortet B, Flipo RM, Remy-Jardin M, et al.: Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1995, 54:815–819.

    Article  CAS  PubMed  Google Scholar 

  9. Demir R, Bodur H, Tokoglu F, et al.: High resolution computed tomography of the lungs in patients with rheumatoid arthritis. Rheumatol Int 1999, 19:19–22.

    Article  CAS  PubMed  Google Scholar 

  10. Gabbay E, Tarala R, Will R, et al.: Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997, 156:528–535.

    CAS  PubMed  Google Scholar 

  11. Georgiadis AN, Metafratzi ZM, Drosos AA: Pulmonary abnormalities in patients with early and longstanding rheumatoid arthritis. J Rheumatol 2009, 36:444–445; author reply 445–446.

    Article  PubMed  Google Scholar 

  12. • Kelly C, Saravanan V: Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease. Expert Opin Pharmacother 2008, 9:3221–3230. In addition to reviewing therapeutic approaches for RA-ILD, this article further defines the radiographic, histopathologic, and epidemiologic characteristics of this extra-articular complication.

    Article  CAS  PubMed  Google Scholar 

  13. •• Kim EJ, Elicker BM, Maldonado F, et al.: Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010, 35:1322–1328. This study suggests that UIP is the most common subtype of RA-ILD, with a poor prognosis paralleling that of IPF.

    Article  CAS  PubMed  Google Scholar 

  14. •• Mori S, Cho I, Koga Y, Sugimoto M: Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008, 35:1513–1521. This prospective study of 126 patients with early and late RA demonstrates significant rates of specific HRCT abnormalities that define radiographic categories corresponding to NSIP, UIP, cryptogenic organizing pneumonia, and bronchiolitis. Equally important, these radiographically defined subtypes are associated with characteristic pulmonary function test abnormalities.

    PubMed  Google Scholar 

  15. Tanaka N, Kim JS, Newell JD, et al.: Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004, 232:81–91.

    Article  PubMed  Google Scholar 

  16. • Koduri G, Norton S, Young A, et al.: Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 2010 Mar 11 (Epub ahead of print). In this large inception cohort of patients with RA observed for up to 20 years (median follow-up period, 10 years), the authors determined that the annualized incidence of clinically evident RA-ILD was 4.1 per 1000 people. More significantly, this study indicates that the mortality rate among patients with clinically evident RA-ILD is greater than 50%, with a median survival of 3 years.

  17. •• Bongartz T, Nannini C, Medina-Velasquez YF, et al.: Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population based study. Arthritis Rheum 2010, 62:1583–1591. This important population-based study from Olmstead County, MN, provides a detailed quantitative analysis of mortality attributable to RA-ILD, indicating that the percent of excess mortality in RA due to ILD is comparable to rates associated with congestive heart failure. The authors also demonstrate that older age, male gender, and increased articular disease severity correlate with the development of RA-ILD.

    Article  PubMed  Google Scholar 

  18. • Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM: Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009, 33:882–896. This review evaluates the radiographic incidence of RA-ILD and the impact of this pulmonary complication on mortality in RA.

    Article  CAS  PubMed  Google Scholar 

  19. Dawson JK, Fewins HE, Desmond J, et al.: Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 2002, 61:517–521.

    Article  CAS  PubMed  Google Scholar 

  20. Naz SM, Symmons DP: Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007, 21:871–883.

    Article  PubMed  Google Scholar 

  21. Toyoshima H, Kusaba T, Yamaguchi M: [Cause of death in autopsied RA patients]. Ryumachi 1993, 33:209–214.

    CAS  PubMed  Google Scholar 

  22. Leslie KO, Trahan S, Gruden J: Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007, 28:369–378.

    Article  PubMed  Google Scholar 

  23. Lee HK, Kim DS, Yoo B, et al.: Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127:2019–2027.

    Article  PubMed  Google Scholar 

  24. Brusselle G: Rheumatoid arthritis and interstitial lung disease: a dangerous liaison. Rheumatology (Oxford) 2010 Mar 11 (Epub ahead of print).

  25. • Kim EJ, Collard HR, King TE Jr: Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009, 136:1397–1405. This article focuses on the relationship between HRCT findings and histologic subtype of RA-ILD. Based on this correlation between radiographic abnormalities and histopathology, the authors propose an algorithm for screening and monitoring of RA-ILD.

    Article  PubMed  Google Scholar 

  26. Yoshinouchi T, Ohtsuki Y, Fujita J, et al.: Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005, 26:121–125.

    Article  CAS  PubMed  Google Scholar 

  27. • Marten K, Dicken V, Kneitz C, et al.: Computer-assisted quantification of interstitial lung disease associated with rheumatoid arthritis: preliminary technical validation. Eur J Radiol 2009, 72:278–283. In this interesting analysis, the authors used computerized quantification of HRCT abnormalities to demonstrate correlations with pulmonary function parameters that include D L CO and FVC.

    Article  CAS  PubMed  Google Scholar 

  28. Rajasekaran A, Shovlin D, Saravanan V, et al.: Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. J Rheumatol 2006, 33:1250–1253.

    PubMed  Google Scholar 

  29. Park JH, Kim DS, Park IN, et al.: Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007, 175:705–711.

    Article  PubMed  Google Scholar 

  30. Klareskog L, Stolt P, Lundberg K, et al.: A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38–46.

    Article  CAS  PubMed  Google Scholar 

  31. Nijenhuis S, Zendman AJ, Vossenaar ER, et al.: Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 2004, 350:17–34.

    Article  CAS  PubMed  Google Scholar 

  32. Makrygiannakis D, Hermansson M, Ulfgren AK, et al.: Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008, 67:1488–1492.

    Article  CAS  PubMed  Google Scholar 

  33. Bongartz T, Cantaert T, Atkins SR, et al.: Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2007, 46:70–75.

    Article  CAS  Google Scholar 

  34. Alexiou I, Germenis A, Koutroumpas A, et al.: Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008, 27:511–513.

    Article  PubMed  Google Scholar 

  35. Inui N, Enomoto N, Suda T, et al.: Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 2008, 41:1074–1077.

    Article  CAS  PubMed  Google Scholar 

  36. Bringardner BD, Baran CP, Eubank TD, Marsh CB: The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 2008, 10:287–301.

    Article  CAS  PubMed  Google Scholar 

  37. Wilson MS, Wynn TA: Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2009, 2:103–121.

    Article  CAS  PubMed  Google Scholar 

  38. Pardo A, Gibson K, Cisneros J, et al.: Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005, 2:e251.

    Article  PubMed  Google Scholar 

  39. Agostini C, Gurrieri C: Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006, 3:357–363.

    Article  CAS  PubMed  Google Scholar 

  40. Rao RN, Goodman LR, Tomashefski JF Jr: Smoking-related interstitial lung disease. Ann Diagn Pathol 2008, 12:445–457.

    Article  PubMed  Google Scholar 

  41. Saag KG, Kolluri S, Koehnke RK, et al.: Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996, 39:1711–1719.

    Article  CAS  PubMed  Google Scholar 

  42. Thorley AJ, Tetley TD: Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007, 2:409–428.

    CAS  PubMed  Google Scholar 

  43. Yang Q, Underwood MJ, Hsin MK, et al.: Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab 2008, 9:661–667.

    Article  CAS  PubMed  Google Scholar 

  44. Rosas IO, Richards TJ, Konishi K, et al.: MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008, 5:e93.

    Article  PubMed  Google Scholar 

  45. Kinoshita F, Hamano H, Harada H, et al.: Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. Respir Med 2004, 98:1131–1137.

    Article  PubMed  Google Scholar 

  46. Oyama T, Kohno N, Yokoyama A, et al.: Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin. Lung 1997, 175:379–385.

    Article  CAS  PubMed  Google Scholar 

  47. Saketkoo LA, Espinoza LR: Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug. Arch Intern Med 2008, 168:1718–1719.

    Article  PubMed  Google Scholar 

  48. Afeltra A, Zennaro D, Garzia P, et al.: Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol 2006, 35:388–394.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

Dr. Ascherman has been awarded a research grant by the American College of Rheumatology Research and Education Foundation to develop peripheral blood biomarkers of RA-ILD.

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dana P. Ascherman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ascherman, D.P. Interstitial Lung Disease in Rheumatoid Arthritis. Curr Rheumatol Rep 12, 363–369 (2010). https://doi.org/10.1007/s11926-010-0116-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-010-0116-z

Keywords

Navigation